Shaikh Abdul Rashid, Mirani Abdul Haleem, Memon Muhammad Saleh, Fahim Muhammad Faisal
Abdul Rashid Shaikh, Department of Ophthalmology, Al Ibrahim Eye Hospital, Isra postgraduate Institute of Ophthalmology, Gaddap Town, Malir, Karachi, Pakistan.
Abdul Haleem Mirani, Department of Ophthalmology, Al Ibrahim Eye Hospital, Isra postgraduate Institute of Ophthalmology, Gaddap Town, Malir, Karachi, Pakistan.
Pak J Med Sci. 2017 May-Jun;33(3):691-694. doi: 10.12669/pjms.333.12589.
To compare the visual outcomes of phacoemulsification surgery with intraocular lens (IOL) in persons with and without diabetes at end of follow-up.
This was a comparative, cross sectional, observational study with Non-probability, purposive sampling. After approval from "Research Ethical Committee of Isra Post-graduate Institute of Ophthalmology Karachi, 92 patients with cataract in one eye were selected. Patients were divided into two groups. Group A consisted of 48 diabetics and group B consisted of 44 non- diabetics with or without diabetes in the age group ≥ 30 years were included. Patients with small Pupil, Pseudo exfoliation Syndrome, Diabetic Retinopathy, and positive history of Uveitis, Glaucoma, and Macular Degeneration were excluded. Data analysis was performed by SPSS Version 20.0.
Best Corrected Visual Acuity (BCVA) in diabetic patients improved from 0.813 ± 0.181 Log MAR pre operatively to 0.183 ± 0.143 after the period of six months post-operatively. Corresponding results in non-diabetics were 0.66 ± 0.31 and 0.08 ± 0.092 Log Mar (P value = 0.001). If WHO criteria was considered, 87.5% diabetics and 92% non-diabetics achieved normal vision (Log Mar 0 to 0.5; ≥ 6/12,) on the first post-operative day. Remaining 12.5% diabetics and 8% non-diabetics achieved moderate vision (0.6 to 1 Log MAR) on first post-operative day improving to normal vision within a week.
Visual outcomes in diabetics after phacoemulsification with intra ocular lens implant is almost as good as that in non-diabetic patient if the diabetics have no retinopathy and have good glycemic control.
比较白内障超声乳化联合人工晶状体(IOL)植入术后随访末期糖尿病患者与非糖尿病患者的视力结果。
这是一项采用非概率、目的抽样的比较性横断面观察研究。经“卡拉奇伊斯拉眼科研究生学院研究伦理委员会”批准,选取92例单眼白内障患者。患者分为两组。A组由48例糖尿病患者组成,B组由44例非糖尿病患者组成,纳入年龄≥30岁的糖尿病患者或非糖尿病患者。排除小瞳孔、假性剥脱综合征、糖尿病视网膜病变以及葡萄膜炎、青光眼和黄斑变性阳性病史的患者。采用SPSS 20.0版进行数据分析。
糖尿病患者的最佳矫正视力(BCVA)从术前的0.813±0.181 Log MAR提高到术后6个月时的0.183±0.143。非糖尿病患者的相应结果分别为0.66±0.31和0.08±0.092 Log Mar(P值=0.001)。若按照世界卫生组织标准,87.5%的糖尿病患者和92%的非糖尿病患者在术后第一天达到正常视力(Log Mar 0至0.5;≥6/12)。其余12.5%的糖尿病患者和8%的非糖尿病患者在术后第一天达到中度视力(0.6至1 Log MAR),并在一周内提高到正常视力。
如果糖尿病患者没有视网膜病变且血糖控制良好,白内障超声乳化联合人工晶状体植入术后的视力结果与非糖尿病患者几乎一样好。